Evolent Health Announces Second Quarter 2019 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- Needham Starts NeoVolta (NEOV) at Buy
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Evolent Health (EVH) PT Lowered to $16 at Cantor Fitzgerald
August 7, 2019 9:02 AM EDTCantor Fitzgerald analyst Steven Halper lowered the price target on Evolent Health (NYSE: EVH) to $16.00 (from $18.00) while maintaining a Overweight rating.
... MoreEvolent Health (EVH) Misses Q2 EPS by 3c; Offers Q3 & FY19 Revenues Guidance
August 6, 2019 4:47 PM EDTEvolent Health (NYSE: EVH) reported Q2 EPS of ($0.26), $0.03 worse than the analyst estimate of ($0.23). Revenue for the quarter came in at $192.1 million versus the consensus estimate of $192.61 million.
Adjusted Revenue of $192.1 million and $144.5 million for the three months ended June 30, 2019 and 2018, respectively, an increase of 32.9%;Adjusted Services Revenue of $149.7 million and $125.4 million for the three months ended June 30, 2019 and 2018, respectively, before intersegment eliminations of $3.1 million and $3.6 million, respectively; andTrue Health premiums revenue of $45.8 million and $22.9 million for the three months ended June 30, 2019 and 2018, respectively, before intersegment eliminations of $0.3 million and $0.2 million,... More